**Page:** 9

## Alphabet Inc. CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions; unaudited)

|                                                                        | Three Months Ended March 31,   | Three Months Ended March 31,   |
|------------------------------------------------------------------------|--------------------------------|--------------------------------|
|                                                                        | 2024                           | 2025                           |
| Operating activities                                                   |                                |                                |
| Net income                                                             | $ 23,662                       | $ 34,540                       |
| Adjustments:                                                           |                                |                                |
| Depreciation of property and equipment                                 | 3,413                          | 4,487                          |
| Stock-based compensation expense                                       | 5,264                          | 5,516                          |
| Deferred income taxes                                                  | 419                            | (1,152)                        |
| Loss (gain) on debt and equity securities, net                         | (1,781)                        | (9,960)                        |
| Other                                                                  | 334                            | 481                            |
| Changes in assets and liabilities, net of effects of acquisitions:     |                                |                                |
| Accounts receivable, net                                               | 3,167                          | 1,638                          |
| Income taxes, net                                                      | 3,011                          | 7,197                          |
| Other assets                                                           | (1,000)                        | (1,288)                        |
| Accounts payable                                                       | (2,124)                        | (880)                          |
| Accrued expenses and other liabilities                                 | (5,054)                        | (5,045)                        |
| Accrued revenue share                                                  | (322)                          | 116                            |
| Deferred revenue                                                       | (141)                          | 500                            |
| Net cash provided by operating activities                              | 28,848                         | 36,150                         |
| Investing activities                                                   |                                |                                |
| Purchases of property and equipment                                    | (12,012)                       | (17,197)                       |
| Purchases of marketable securities                                     | (20,684)                       | (18,453)                       |
| Maturities and sales of marketable securities                          | 24,985                         | 20,345                         |
| Purchases of non-marketable securities                                 | (1,206)                        | (958)                          |
| Maturities and sales of non-marketable securities                      | 313                            | 259                            |
| Acquisitions, net of cash acquired, and purchases of intangible assets | (61)                           | (340)                          |
| Other investing activities                                             | 101                            | 150                            |
| Net cash used in investing activities                                  | (8,564)                        | (16,194)                       |
| Financing activities                                                   |                                |                                |
| Net payments related to stock-based award activities                   | (2,929)                        | (3,110)                        |
| Repurchases of stock                                                   | (15,696)                       | (15,068)                       |
| Dividend payments                                                      | 0                              | (2,434)                        |
| Proceeds from issuance of debt, net of costs                           | 1,982                          | 4,532                          |
| Repayments of debt                                                     | (3,079)                        | (4,521)                        |
| Proceeds from sale of interest in consolidated entities, net           | 8                              | 400                            |
| Net cash used in financing activities                                  | (19,714)                       | (20,201)                       |
| Effect of exchange rate changes on cash and cash equivalents           | (125)                          | 43                             |
| Net increase (decrease) in cash and cash equivalents                   | 445                            | (202)                          |
| Cash and cash equivalents at beginning of period                       | 24,048                         | 23,466                         |
| Cash and cash equivalents at end of period                             | $ 24,493                       | $ 23,264                       |